Factors influencing dosing and concentrations of sirolimus in de novo heart transplant recipients.

被引：0
|
作者：
Akhlaghi, F
Zahir, H
Keogh, AM
机构：
[1] Univ Rhode Isl, Kingston, RI 02881 USA
[2] St Vincents Hosp, Heart Lung Transplant Unit, Sydney, NSW 2010, Australia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
049
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [21] A clinical experience with Gengraf™ (Abbott cyclosporine) in de novo renal transplant recipients.
    Scandling, J
    Rajagopalan, PR
    Magee, J
    Conti, D
    Mendez, R
    Bronson, D
    Awni, W
    Nabulsi, A
    Hoffman, R
    TRANSPLANTATION, 2000, 69 (08) : S161 - S161
  • [22] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
  • [23] Risk factors for chronic renal failure in heart transplant recipients.
    Esposito, C
    Bellotti, N
    Semeraro, L
    Fasoli, G
    Fornoni, A
    Soccio, G
    Klersy, C
    Sozze, E
    Campana, C
    Gavazzi, A
    DalCanton, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3311 - A3311
  • [24] Retrospective review of sirolimus use for chronic rejection and renal dysfunction in heart transplant recipients.
    Lehneman, JB
    Smallwood, GA
    D'Amico, C
    Vega, D
    Smith, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 177 - 177
  • [25] Racial Differences in Tacrolimus Xr Dosing in De Novo Kidney Transplant Recipients
    Patel, N.
    Carcella, T.
    Bartlett, F.
    Rohan, V.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 818 - 818
  • [26] Analysis of Predictive and Preventive Factors for De Novo DSA in Non-HLA Sensitized Kidney Transplant Recipients.
    Hirai, T.
    Shibahara, R.
    Sawada, Y.
    Toki, D.
    Nozaki, T.
    Omoto, K.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 579 - 579
  • [27] Analysis of Predictive and Preventive Factors for De Novo DSA in Non-HLA Sensitized Kidney Transplant Recipients.
    Hirai, T.
    Shibahara, R.
    Sawada, Y.
    Toki, D.
    Nozaki, T.
    Omoto, K.
    Ishida, H.
    Tanabe, K.
    TRANSPLANTATION, 2014, 98 : 579 - 579
  • [28] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [29] Post-transplant de novo malignancies in pediatric renal transplant recipients: Conversion to sirolimus immunosuppression
    Garcia, C.
    Bittencourt, V.
    Malheiros, D.
    Tumelero, A.
    Antonello, J.
    Oliveira, A.
    Garcia, V.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1478 - 1478
  • [30] Neoral once daily dosing utilizing trough and C2 monitoring in de novo living donor liver transplant recipients.
    Ogura, Yasuhiro
    Oike, Fumitaka
    Takada, Yasutsugu
    Tanaka, Koichi
    Masuda, Satohiro
    Yano, Ikuko
    Inui, Ken-ichi
    Uemoto, Shinji
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 551 - 551
12345